IMG Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$50.7K Buy
194
+36
+23% +$9.23K 0.03% 190
2026
Q2
$39.8K Buy
158
+153
+3,060% +$32.9K 0.02% 200
2026
Q1
$1.09K Sell
5
-187
-97% -$41.5K ﹤0.01% 471
2025
Q4
$43.9K Buy
192
+98
+104% +$22.3K 0.03% 174
2025
Q3
$21.8K Hold
94
– – 0.01% 198
2025
Q2
$17.4K Buy
+94
New +$17.5K 0.01% 209

Other funds holding ABBV

IMG Wealth Management's ABBV Position: Q3 2026 in Review

IMG Wealth Management increased its AbbVie (ABBV) stake by 23% in Q3 2026, buying an estimated $9.23K and bringing the position to 194 shares worth $50.7K. The position accounts for 0.03% of the portfolio, ranked #190.

IMG Wealth Management first reported a position in ABBV in Q2 2025 and has held it in 6 quarters since. 1,999 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • IMG Wealth Management held 194 shares of AbbVie worth $50.7K as of Q3 2026.
  • IMG Wealth Management bought 36 AbbVie shares in Q3 2026, an estimated $9.23K.
  • AbbVie made up 0.03% of IMG Wealth Management's portfolio in Q3 2026, its #190 holding.
  • IMG Wealth Management first reported a position in AbbVie in Q2 2025 and has held it in 6 quarters since.
  • 1,999 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on IMG Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.